Details for New Drug Application (NDA): 022205

✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions

NDA 022205 describes GIAZO, which is a drug marketed by Valeant Pharms Intl and is included in one NDA. There are four patents protecting this drug and one Paragraph IV challenge. Additional details are available on the GIAZO profile page.

The generic ingredient in GIAZO is balsalazide disodium. There are ten drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the balsalazide disodium profile page.

Summary for 022205

Tradename:	GIAZO
Applicant:	Valeant Pharms Intl
Ingredient:	balsalazide disodium
Patents:	4

Profile for product number 001

Active Rx/OTC/Discontinued:	DISCN	Dosage:	TABLET;ORAL			Strength	1.1GM Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons
Approval Date:	Feb 3, 2012	TE:		RLD:	Yes
Patent:	⤷ Try a Trial	Patent Expiration:	Aug 24, 2026	Product Flag?		Substance Flag?		Delist Request?
Patented Use:	TREATMENT OF MILDLY TO MODERATELY ACTIVE ULCERATIVE COLITIS IN MALE PATIENTS
Patent:	⤷ Try a Trial	Patent Expiration:	Aug 24, 2026	Product Flag?		Substance Flag?		Delist Request?
Patented Use:	TREATMENT OF MILDLY TO MODERATELY ACTIVE ULCERATIVE COLITIS IN MALE PATIENTS
Patent:	⤷ Try a Trial	Patent Expiration:	Jun 23, 2031	Product Flag?		Substance Flag?		Delist Request?
Patented Use:	TREATMENT OF MILDLY TO MODERATELY ACTIVE ULCERATIVE COLITIS IN MALE PATIENTS

Expired US Patents for NDA 022205

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Valeant Pharms Intl	GIAZO	balsalazide disodium	TABLET;ORAL	022205-001	Feb 3, 2012	⤷ Try a Trial	⤷ Try a Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.